María del Carmen
Chillón Santos
Investigadora desde 2011
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (5)
2019
-
An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens
Leukemia and Lymphoma, Vol. 60, Núm. 4, pp. 1030-1035
2018
-
Focal adhesion genes refine the intermediate-risk cytogenetic classification of acute myeloid leukemia
Cancers, Vol. 10, Núm. 11
2017
-
NEDD 9 an independent good prognostic factor in intermediaterisk acute myeloid leukemia patients
Oncotarget, Vol. 8, Núm. 44, pp. 76003-76014
2015
-
CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia
Haematologica
-
Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: Phase Ib/II panobidara study
Haematologica, Vol. 100, Núm. 10, pp. 1294-1300